[go: up one dir, main page]

EE200200105A - Radiofarmatseutilised saadused ja nende valmistamise meetod - Google Patents

Radiofarmatseutilised saadused ja nende valmistamise meetod

Info

Publication number
EE200200105A
EE200200105A EEP200200105A EEP200200105A EE200200105A EE 200200105 A EE200200105 A EE 200200105A EE P200200105 A EEP200200105 A EE P200200105A EE P200200105 A EEP200200105 A EE P200200105A EE 200200105 A EE200200105 A EE 200200105A
Authority
EE
Estonia
Prior art keywords
radiopharmaceuticals
preparation
Prior art date
Application number
EEP200200105A
Other languages
English (en)
Inventor
Bellande Emmanuel
Jallet Pierre
Denizot Beno�t
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200105A publication Critical patent/EE200200105A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/06Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
EEP200200105A 1999-09-01 2000-08-23 Radiofarmatseutilised saadused ja nende valmistamise meetod EE200200105A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910970A FR2797769B1 (fr) 1999-09-01 1999-09-01 Produits radiopharmaceutiques et leur procede de preparation
PCT/IB2000/001161 WO2001015746A1 (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure

Publications (1)

Publication Number Publication Date
EE200200105A true EE200200105A (et) 2003-04-15

Family

ID=9549465

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200105A EE200200105A (et) 1999-09-01 2000-08-23 Radiofarmatseutilised saadused ja nende valmistamise meetod

Country Status (23)

Country Link
EP (1) EP1210127A1 (et)
JP (1) JP2003508455A (et)
KR (1) KR20020040799A (et)
CN (1) CN1371292A (et)
AU (1) AU6463100A (et)
BG (1) BG106438A (et)
BR (1) BR0013729A (et)
CA (1) CA2383517A1 (et)
CZ (1) CZ2002782A3 (et)
EA (1) EA200200307A1 (et)
EE (1) EE200200105A (et)
FR (1) FR2797769B1 (et)
HK (1) HK1044893A1 (et)
HU (1) HUP0202714A2 (et)
IL (1) IL148076A0 (et)
MX (1) MXPA02001923A (et)
NO (1) NO20021001L (et)
NZ (1) NZ517377A (et)
PL (1) PL353803A1 (et)
SK (1) SK2772002A3 (et)
WO (1) WO2001015746A1 (et)
YU (1) YU14202A (et)
ZA (1) ZA200201057B (et)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
FR2919189A1 (fr) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres.
CN102977174B (zh) * 2012-12-19 2015-04-22 北京师范大学 99mTc(CO)3核标记大环多胺三唑环类葡萄糖基配合物及制备方法和应用
PL240772B1 (pl) 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Sposób wytwarzania nanocząstek polimerowych chelatujących izotopy promieniotwórcze do zastosowania w diagnostyce i terapii

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7412164L (sv) * 1974-09-27 1976-03-29 Pharmacia Ab Medel for intravaskuler administrering
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
AU5085793A (en) * 1992-09-04 1994-03-29 General Hospital Corporation, The Biocompatible polymers containing diagnostic or therapeutic moieties
US5958372A (en) * 1994-06-28 1999-09-28 Nycomed Imaging As Low viscosity chelating polymers for diagnostic imaging
FR2736834B1 (fr) * 1995-07-17 1997-08-29 Cis Bio Int Produits radiopharmaceutiques a tropisme cardiaque comportant un complexe nitruro d'un metal de transition et ayant une clairance myocardique rapide

Also Published As

Publication number Publication date
CZ2002782A3 (cs) 2002-08-14
SK2772002A3 (en) 2002-09-10
KR20020040799A (ko) 2002-05-30
NO20021001D0 (no) 2002-02-28
MXPA02001923A (es) 2003-07-21
PL353803A1 (en) 2003-12-01
NZ517377A (en) 2003-08-29
FR2797769A1 (fr) 2001-03-02
IL148076A0 (en) 2002-09-12
CA2383517A1 (en) 2001-03-08
AU6463100A (en) 2001-03-26
EA200200307A1 (ru) 2002-08-29
HK1044893A1 (zh) 2002-11-08
FR2797769B1 (fr) 2003-07-25
CN1371292A (zh) 2002-09-25
YU14202A (sh) 2004-09-03
BG106438A (bg) 2002-09-30
NO20021001L (no) 2002-04-11
WO2001015746A1 (en) 2001-03-08
JP2003508455A (ja) 2003-03-04
ZA200201057B (en) 2003-07-30
BR0013729A (pt) 2002-05-07
EP1210127A1 (en) 2002-06-05
HUP0202714A2 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
EE200200105A (et) Radiofarmatseutilised saadused ja nende valmistamise meetod
FI973733L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI19992360L (fi) Tuote ja menetelmä sen valmistamiseksi
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
EE200200241A (et) Suhkurtõvevastane preparaat ja meetod
EE04418B1 (et) Moksifloksatsiini farmatseutiline preparaat
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
FI20012462L (fi) Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
IL148247A0 (en) A vaccine composition and method of using the same
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
FI981506A0 (fi) Elastomeerikompositio ja sen valmistusmenetelmä
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
EE04154B1 (et) Omeprasooli valmistamise meetod
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
PT1228056E (pt) Metodo de preparacao de citaloprame
EE04553B1 (et) 15-llilised 8a- ja 9a-laktaamid ning nende valmistamismeetod
EE05230B1 (et) Suukaudselt manustatav galantamiinilahus ja meetod selle valmistamiseks
FI20001716L (fi) Rankajõrjestely ja siihen liittyvõt menetelmõt
PT1230212E (pt) Metodo de embalar elementos de construcao de brinquedo
FI19992817L (fi) Rakennustekninen menetelmä ja laite
FI991050L (fi) Lateksikoostumukset ja niiden valmistamismenetelmä
FI974235A0 (fi) Ny bestaemningsmetod